Top Markets
Coin of the day
CSL Limited CSL Limited

CSL Limited

CSL
Rang in Aktien #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Aktienkurs
$99.32
Marktkapitalisierung
$48.20B
Veränderung (1 Tag)
0.98%
Veränderung (1 Jahr)
-32.14%
Land
AU
Handel CSL Limited (CSL)

Kategorie

Aktien-Split-Historie für CSL Limited (CSL)
Die Aktie CSL Limited (Symbol: CSL) durchlief insgesamt 1 Aktiensplits.
Der letzte Aktiensplit fand am Oct 18, 2007 statt.
Eine CSL-Aktie, die vor dem Oct 18, 2007 gekauft wurde, entspricht heute 3 CSL-Aktien.
Liste der Aktiensplits
Jahr Aktien-Split Multiplikator Kumulierter Multiplikator
2007-10-18 3:1 x3 x3
Aktiensplits ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Aktiensplits Kumulierter Multiplikator Land
5 x199
DK
1 x2
US
0 -
US
0 -
BE
0 -
NL